Turns out, it's very hard to remove a test subject's own bias about their psychedelic test treatment.
The hype has been deafening on psychedelics as a promising treatment for depression, sometimes justified, sometimes not. Seemingly everything, from DMT toBut a sweeping new review scrutinizing the results of two dozen clinical trials has brought the volume down a little on that noise.
A trio of psychiatric researchers from London, Philadelphia, and San Francisco have determined that, at least, some of the positive benefits attributed to psychedelics can be chalked up to theQuite simply, you can’t not know when you’re taking psychedelics. No matter how hard clinical researchers try, their patient volunteers are always well aware of the fact that they’re tripping. That reality has put traditional antidepressants at a disadvantage in clinical studies. In these studies, researchers are much more capable of neutralizing a subject’s awareness that they’re taking the actual drug versus an inert placebo via various “blinding” or treatment-anonymizing strategies. So, in order to level the playing field, the team restricted their new meta-analysis to only “open label” trials of traditional antidepressants—meaning studies that did not include “blinding”—for a fairer comparison against clinical studies that have examined psychedelics as antidepressants.Psychedelics and traditional antidepressants, the team found, performed more-or-less just as effectively as one another. In fact, traditional antidepressants appeared to just slightly outperform psychedelics by 0.3 units on a common depression-rating questionnaire for patients, the Hamilton Depression Rating Scale . The difference was not enough to prove either drug class as better in any statistically or clinically significant way, as they“Our results do not disprove the exciting results about psychedelic treatments,” study coauthor Balázs Szigeti, a clinical data scientist at the University of California, San Francisco , emphasized to“It is just that they are not more effective than open-label traditional antidepressants,” he explained, “which feels underwhelming given the attention.”Traditionally, whenever depression researchers have attempted to test psychedelics against a true inactive placebo, as a control, the mind-expanding drugs have dramatically outperformed. Based on a 17-item version of the HAM-D, researchers found that psychedelics typically scored a mean of 7.3 HAM-D units better than a placebo. Conventional antidepressants, by contrast, only fared about 2.4 HAM-D units better than their placebos. The researchers combed through the peer-reviewed journal literature, considering and discarding nearly 600 studies before landing on the 24 that helped them develop a more fair basis of comparison. They focused on 16 open-label trials of traditional antidepressants, with a total of 7,921 patients, in which the participants were expressly told whether they were taking the real drug or the placebo. They then compared these to eight studies of psychedelics, with a total of 249 patients, in which patients really couldn’t help but notice which kind of pill they had swallowed. Despite all that effort, however, some researchers felt the team might have introduced errors by collating studies that could vary in terms of patient inclusion criteria, total sample size of the patient pool, and other factors. Robin Carhart-Harris, a professor of neurology and psychiatry at UCSF who was unaffiliated with the work, described the results to New Scientist as inconclusive. “It’s proposed as comparing apples with apples, when really it’s more like comparing apples with oranges,” said Carhart-Harris, whose own work has Clearly, a mind-expanding, higher consciousness will be needed to devise new testing methods that could finally remove these unintended biases from future psychedelics research. But for now, it’s not about the destination. It’s the trip.4:00 pmLSD Could Offer a Next-Gen Treatment for AnxietyMicrodosing LSD Won’t Really Help Your ADHD, Trial Finds People who took twice-weekly low doses of LSD experienced no greater improvement in their ADHD symptoms than people taking placebo.Ancient Egyptians Mixed Psychedelics, Bodily Fluids, and Alcohol for Rituals, Scientists Confirm
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
NYC's crackdown on reckless e-biker riders is over as Mamdani pumps the brakesToday's Video Headlines: 03/18/26
Read more »
Volunteers spend 30 years restoring a Victorian sewer pump stationAndrew Paul is Popular Science's staff writer focused primarily on tech, AI, physics, and culture news. He was previously a regular contributor to The A.V. Club and Input, and has been featured by Rolling Stone, Fangoria, GQ, Slate, NBC, McSweeney's Internet Tendency, and elsewhere. He lives outside Indianapolis.
Read more »
Some California Democrats pitch gas price relief as prices at the pump soarCalMatters is a nonpartisan and nonprofit news organization dedicated to serving the state of California.
Read more »
Some California Democrats pitch gas price relief as prices at the pump soarTwo Democrats running for governor want to cut gas taxes and environmental regulations as prices soar during the war in Iran.
Read more »
North Texas drivers feeling effects of the Iran war at the gas pumpThe average price of a gallon of gas has been steadily going up around the country since the beginning of the U.S. conflict with Iran, and North Texas drivers are feeling the effects.
Read more »
Not so fast: Denver Transportation and Infrastructure Committee pumps the brakes on new scooter contractMaggy Wolanske is a multimedia journalist with Denver7.
Read more »